Promising drug aims to close painful fistulas in Crohn's patients
Disease control
Ongoing
This study tests a drug called guselkumab in 288 people with Crohn's disease who have painful tunnels (fistulas) near the anus. The goal is to see if the drug can close these fistulas completely, as confirmed by MRI scans, and keep them closed for up to 48 weeks. Participants rec…
Phase: PHASE3 • Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Apr 29, 2026 02:05 UTC